On August 23, 2026, the Sun Yat-sen University Intelligent Life Manufacturing Innovation Project Promotion Conference, hosted by the School of Future Biomedicine of Sun Yat-sen University, was held at the Canton Fair Complex in Guangzhou. As a core event of the 2026 Guangzhou Medical and Health Industry Expo, the promotion conference unveiled nine cutting-edge innovative achievements developed by Sun Yat-sen University and its affiliated hospitals covering smart healthcare, organoids, pathological AI and other fields, aiming to break through bottlenecks restricting the translation of lab research to industrial production lines. Leaders of the People’s Government of Guangzhou Municipality, Prof. Tian Linxin, Vice President of Sun Yat-sen University and Dean of the School of Future Biomedicine, and Li Tiegang, Deputy Director of Guangzhou Municipal Health Commission attended the conference. Prof. Zhang Yan, Vice Dean of the School of Future Biomedicine, presided over the event.

In the opening address, representatives of the Guangzhou Municipal Government pointed out that Sun Yat-sen University serves as a core engine of Guangzhou’s biomedical innovation ecosystem, and its affiliated hospital cluster ranks among the top original innovation powerhouses for biomedicine in the city. In 2025, the total revenue from technology transfer of major affiliated hospitals of Sun Yat-sen University exceeded RMB 250 million. The Sun Yat-sen University Cancer Center carried out 695 ongoing GCP clinical trials with a total contract value of RMB 270 million; the First Affiliated Hospital of Sun Yat-sen University licensed 30 patents worth a contractual sum of RMB 72.29 million, both topping the list of the Guangzhou Alliance of Research Hospitals. Currently, Guangzhou is accelerating the construction of the National University Regional Biomedical Technology Transfer Center (Guangdong-Hong Kong-Macao Greater Bay Area), continuously advancing in-depth collaboration between Sun Yat-sen University and multi-industry platforms to boost the development of local healthcare undertakings and biomedical industry.

Core Highlight: Roadshow of Nine Frontier Projects Covering the Entire R&D-Translation-Treatment Industrial Chain

At the conference, project representatives from the First Affiliated Hospital of Sun Yat-sen University, Zhongshan Ophthalmic Center, School of Biomedical Engineering, Innovent Biologics, Sevision, Saitro Biotech and other institutions delivered presentations on innovative projects one after another.

Smart Diagnosis & Treatment Sector

• Prof. Lei Wenbin, Director of Otorhinolaryngology, First Affiliated Hospital of SYSU: Construction and Clinical Translation of Multi-modal AI Diagnosis & Treatment Model for Head and Neck Throat Tumors

• Prof. Li Tao, Deputy Director of Zhongshan Ophthalmic Center: Smart Mobile Eye Health Screening Scenarios

• Lin Zhenzhe, Director of Digital Intelligent Technology R&D & Application Department, Zhongshan Ophthalmic Center: Chongming – Portable Intelligent Anterior Segment Screening Device

• Chen Rui, Chairman of Sevision (Guangzhou) Medical Technology Service Co., Ltd.: The Evolution of Pathological AI from Urological Tumors to Pan-Cancer Detection

• Huang Jinbo, Assistant Research Fellow, Organ Transplant Center, First Affiliated Hospital of SYSU: Organ Medicine: A New Track for Life Sciences

Organoid & Biotherapy Sector

• Prof. Liu Jie, Vice Dean, School of Biomedical Engineering, SYSU: Industrial Translation Research on Organoids and Organ-on-Chip

• Prof. Wang Shanquan, School of Environmental Science and Engineering, SYSU: Development of X-Gutor Intestinal Organoid System and Its Application in Intestinal Health

• Zhang Lifeng, Chairman of Shenzhen Saitro Biotech Medical Technology Co., Ltd.: From Lab to Factory: R&D Practice of Industrial GMP Cell Preparation System

• Pan Fengchao, Director of Product Portfolio, Innovent Biologics: Driven by Innovation, Delivering High-quality Biologics to Patients Worldwide

In addition, Huang Luo, Deputy General Manager of Guangzhou SYSU Science Park Co., Ltd., interpreted the university’s whole-chain scientific achievement transfer system. Dean Tian Linxin stated that Sun Yat-sen University will “promote deep interdisciplinary integration of medicine with life sciences, engineering, materials science, information technology and artificial intelligence, enabling more innovative outcomes to move from laboratories to hospital beds and marketplaces.”

This promotion conference marks a key practice of the School of Future Biomedicine to deepen industry-education integration and integration of science and education. All showcased projects established direct matching channels with top-tier municipal medical institutions, biomedical enterprises and industrial parks, facilitating the convergence of innovation, industry, talent and capital resources. The School of Future Biomedicine will continue to leverage the strengths of a comprehensive research university, proactively align with Guangzhou’s demands for healthcare and industrial development, expand the reach of high-quality medical resources to grassroots levels, and accelerate local industrialization of scientific breakthroughs. With the advancement of the National University Regional Biomedical Technology Transfer Center (GBA) and sustained operation of the School of Future Biomedicine, Sun Yat-sen University is expected to build stronger original innovation capabilities in major disease prevention, novel drugs and high-end medical devices, accelerating the construction of a globally influential biomedical and health industry highland in the Guangdong-Hong Kong-Macao Greater Bay Area.

About the School of Future Biomedicine

Founded in August 2025, the School of Future Biomedicine, Sun Yat-sen University, is a strategic domestic layout targeting cutting-edge life health sectors to fulfill national and regional strategic demands. Rooted in Guangzhou and the Greater Bay Area, the school focuses on core fields including vaccines, antibody drugs, anti-infective therapeutics, stem cell and organ regeneration, and smart healthcare. By building high-level research platforms and recruiting top-tier talents, the school consistently accelerates the local industrial translation of scientific research achievements.

Source: School of Future Biomedicine, Sun Yat-sen University